Quinazoline-2,4(1 H,3 H)-dione Scaffold for development of a novel PARP-targeting PET probe for tumor imaging-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Quinazoline-2,4(1 H,3 H)-dione Scaffold for development of a novel PARP-targeting PET probe for tumor imaging

Published:2024-07-16 Issue: Volume: Page:
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

He Chunfeng,Shi Hui,Tan Boyu,Jiang Zhaoning,Cao Rui,Zhu Jiamin,Qian Kun,Wang Xiao,Xu Xiaoping,Qu Chunrong,Song Shaoli^ORCID,Cheng Zhen^ORCID

Funder

National Natural Science Foundation of China

Shanghai Municipal Science and Technology Major Project

State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences

Gansu Science and Technology Major Project

the Shandong Laboratory Program

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00259-024-06843-2.pdf

Reference41 articles.

1. Schwarz SD, Xu J, Gunasekera K, Schürmann D, Vågbø CB, Ferrari E, et al. Covalent PARylation of DNA base excision repair proteins regulates DNA demethylation. Nat Commun. 2024;15:184. https://doi.org/10.1038/s41467-023-44209-8.

2. Zandarashvili L, Langelier MF, Velagapudi UK, Hancock MA, Steffen JD, Billur R, et al. Structural basis for allosteric PARP-1 retention on DNA breaks. Science. 2020;368:eaax6367. https://doi.org/10.1126/science.aax6367.

3. Curtin NJ, Szabo C. Poly(ADP-ribose) polymerase inhibition: past, present and future. Nat Rev Drug Discovery. 2020;19:711–36. https://doi.org/10.1038/s41573-020-0076-6.

4. Spring LM, Han H, Liu MC, Hamilton E, Irie H, Santa-Maria CA, et al. Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer. Nat Cancer. 2022;3:927–31. https://doi.org/10.1038/s43018-022-00400-2.

5. Gruber JJ, Afghahi A, Timms K, DeWees A, Gross W, Aushev VN, et al. A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination genes. Nat Cancer. 2022;3:1181–91. https://doi.org/10.1038/s43018-022-00439-1.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3